Baudax Bio Price Prediction

BXRXDelisted Stock  USD 0.76  0.06  7.32%   
At this time, The value of RSI of Baudax Bio's share price is at 57 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Baudax Bio, making its price go up or down.

Oversold Vs Overbought

57

 
Oversold
 
Overbought
The successful prediction of Baudax Bio's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Baudax Bio, which may create opportunities for some arbitrage if properly timed.
Using Baudax Bio hype-based prediction, you can estimate the value of Baudax Bio from the perspective of Baudax Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Baudax Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Baudax because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Baudax Bio after-hype prediction price

    
  USD 0.76  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Intrinsic
Valuation
LowRealHigh
0.680.680.84
Details
Naive
Forecast
LowNextHigh
0.680.680.68
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.700.820.94
Details

Baudax Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of Baudax Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Baudax Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Baudax Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Baudax Bio Estimiated After-Hype Price Volatility

In the context of predicting Baudax Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Baudax Bio's historical news coverage. Baudax Bio's after-hype downside and upside margins for the prediction period are 0.76 and 0.76, respectively. We have considered Baudax Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.76
0.76
After-hype Price
0.76
Upside
Baudax Bio is very steady at this time. Analysis and calculation of next after-hype price of Baudax Bio is based on 3 months time horizon.

Baudax Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Baudax Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Baudax Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Baudax Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
2 Events / Month
10 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.76
0.76
0.00 
0.00  
Notes

Baudax Bio Hype Timeline

Baudax Bio is currently traded for 0.76. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Baudax is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Baudax Bio is about 0.0%, with the expected price after the next announcement by competition of 0.76. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Baudax Bio recorded a loss per share of 94.13. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 1st of December 2022. Given the investment horizon of 90 days the next projected press release will be in a few days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Baudax Bio Related Hype Analysis

Having access to credible news sources related to Baudax Bio's direct competition is more important than ever and may enhance your ability to predict Baudax Bio's future price movements. Getting to know how Baudax Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Baudax Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
VRAXVirax Biolabs Group 0.02 4 per month 0.00 (0.11) 9.65 (12.90) 61.28 
YSYS Biopharma Co, 0.12 2 per month 0.00 (0.10) 10.29 (10.53) 36.81 
NEXINeximmune 0.00 0 per month 0.00 (0.04) 5.90 (9.00) 94.30 
CYTOAltamira Therapeutics(0.01)7 per month 0.00 (0.25) 6.98 (10.87) 22.81 
PALIPalisade Bio 0.03 7 per month 0.00 (0.11) 5.97 (8.55) 24.25 
CFRXContraFect Corp 0.01 1 per month 0.00 (0.04) 12.23 (8.45) 55.69 
ALLRAllarity Therapeutics 0.07 10 per month 0.00 (0.26) 10.85 (16.11) 41.48 
CNSPCns Pharmaceuticals(0.01)7 per month 0.00 (0.07) 9.09 (11.76) 39.29 
WINTWindtree Therapeutics(0.04)7 per month 0.00 (0.28) 12.00 (18.48) 62.78 
QNRXQuoin Pharmaceuticals Ltd(0.03)10 per month 6.79  0.03  17.65 (9.68) 74.46 
KRBPKiromic Biopharma(0.24)3 per month 0.00 (0.03) 12.04 (10.96) 65.24 
BDRXBiodexa Pharmaceticals 0.40 9 per month 0.00 (0.11) 11.91 (17.24) 97.78 
NRBONeurobo Pharmaceuticals(0.22)6 per month 0.00 (0.12) 6.76 (7.34) 25.62 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.06) 8.33 (7.89) 113.15 
DRMADermata Therapeutics 0.04 3 per month 0.00 (0.06) 9.22 (8.05) 69.06 
ENSCEnsysce Biosciences 0.00 7 per month 10.13  0.09  27.27 (20.00) 184.26 
PBLAPanbela Therapeutics 0.00 0 per month 0.00 (0.21) 10.70 (17.30) 88.58 

Baudax Bio Additional Predictive Modules

Most predictive techniques to examine Baudax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Baudax using various technical indicators. When you analyze Baudax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Baudax Bio Predictive Indicators

The successful prediction of Baudax Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Baudax Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Baudax Bio based on analysis of Baudax Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Baudax Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Baudax Bio's related companies.

Story Coverage note for Baudax Bio

The number of cover stories for Baudax Bio depends on current market conditions and Baudax Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Baudax Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Baudax Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Baudax Bio Short Properties

Baudax Bio's future price predictability will typically decrease when Baudax Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Baudax Bio often depends not only on the future outlook of the potential Baudax Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Baudax Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding331.6 K
Cash And Short Term Investments5.3 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Baudax Stock

If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance